Company / Capital Expenditures
iBio, Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$210.0K
FY2025
5-year range
$210.0K / $7.3M
FY2021-FY2025
Trend
-96.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 10 years, ranging from $13,000 in FY2016 to $7M in FY2023.
Based on SEC 10-K filings.
$210,000 in FY2025 with a 5-year CAGR of -25.6%.
Declined from $7M to $210,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -65.1%
- 5-Year CAGR
- -25.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -25.6%, indicating a declining trend.
- In FY2025, capital expenditures decreased 96.3% year-over-year.
- Peak capital expenditures was recorded in FY2023.
- Lowest capital expenditures in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.36 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $210.0K | -96.3% |
| FY2024 | $5.7M | -21.7% |
| FY2023 | $7.3M | +49.0% |
| FY2022 | $4.9M | +356.4% |
| FY2021 | $1.1M | +17.2% |
| FY2020 | $920.0K | -1.5% |
| FY2019 | $934.0K | -29.4% |
| FY2018 | $1.3M | +1845.6% |
| FY2017 | $68.0K | +423.1% |
| FY2016 | $13.0K | +225.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026